Family Capital Trust Co decreased its position in Danaher Corp. (NYSE:DHR) by 0.3% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 32,131 shares of the company’s stock after selling 93 shares during the period. Danaher Corp. accounts for about 1.9% of Family Capital Trust Co’s holdings, making the stock its 21st largest position. Family Capital Trust Co’s holdings in Danaher Corp. were worth $3,245,000 at the end of the most recent quarter.
A number of other large investors have also made changes to their positions in DHR. Massmutual Trust Co. FSB ADV raised its stake in shares of Danaher Corp. by 6.0% in the first quarter. Massmutual Trust Co. FSB ADV now owns 41,869 shares of the company’s stock worth $3,972,000 after buying an additional 2,366 shares during the last quarter. Sentry Investment Management LLC raised its stake in shares of Danaher Corp. by 1.9% in the first quarter. Sentry Investment Management LLC now owns 46,181 shares of the company’s stock worth $4,381,000 after buying an additional 870 shares during the last quarter. Bristlecone Advisors LLC raised its stake in shares of Danaher Corp. by 10.1% in the first quarter. Bristlecone Advisors LLC now owns 4,376 shares of the company’s stock worth $415,000 after buying an additional 400 shares during the last quarter. BlackRock Fund Advisors raised its stake in shares of Danaher Corp. by 3.3% in the first quarter. BlackRock Fund Advisors now owns 6,928,859 shares of the company’s stock worth $657,272,000 after buying an additional 218,791 shares during the last quarter. Finally, Franklin Resources Inc. raised its stake in shares of Danaher Corp. by 2.4% in the first quarter. Franklin Resources Inc. now owns 2,390,117 shares of the company’s stock worth $226,727,000 after buying an additional 55,475 shares during the last quarter. Hedge funds and other institutional investors own 75.74% of the company’s stock.
Shares of Danaher Corp. (NYSE:DHR) traded down 0.09% on Friday, reaching $78.25. The company’s stock had a trading volume of 2,608,956 shares. Danaher Corp. has a 1-year low of $61.60 and a 1-year high of $82.64. The firm has a market cap of $54.03 billion, a price-to-earnings ratio of 15.56 and a beta of 1.13. The company’s 50 day moving average is $78.79 and its 200-day moving average is $76.62.
Danaher Corp. (NYSE:DHR) last posted its quarterly earnings data on Monday, July 25th. The company reported $1.25 earnings per share for the quarter, topping the consensus estimate of $1.22 by $0.03. The company earned $5.80 billion during the quarter, compared to analysts’ expectations of $5.76 billion. Danaher Corp. had a return on equity of 13.40% and a net margin of 15.88%. Danaher Corp.’s revenue for the quarter was up 16.6% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.08 earnings per share. Equities research analysts expect that Danaher Corp. will post $3.56 EPS for the current year.
The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 28th. Stockholders of record on Friday, September 30th will be given a dividend of $0.125 per share. The ex-dividend date is Wednesday, September 28th. This represents a $0.50 annualized dividend and a dividend yield of 0.64%. Danaher Corp.’s dividend payout ratio is currently 9.94%.
A number of equities research analysts have commented on the company. Goldman Sachs Group Inc. assumed coverage on Danaher Corp. in a research report on Tuesday, July 5th. They set a “neutral” rating and a $74.00 price objective for the company. Sanford C. Bernstein raised Danaher Corp. from a “market perform” rating to an “outperform” rating and set a $120.00 price target for the company in a research note on Thursday, June 23rd. JPMorgan Chase & Co. reaffirmed a “buy” rating and set a $105.00 price target on shares of Danaher Corp. in a research note on Thursday, June 30th. Citigroup Inc. raised their price target on Danaher Corp. from $102.00 to $104.00 and gave the stock a “neutral” rating in a research note on Monday, June 13th. Finally, Zacks Investment Research downgraded Danaher Corp. from a “hold” rating to a “sell” rating in a research note on Wednesday, June 29th. Eight equities research analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company. The company presently has a consensus rating of “Buy” and an average target price of $93.10.
In related news, insider Thomas Patrick Joyce, Jr. sold 45,897 shares of the stock in a transaction that occurred on Monday, August 1st. The stock was sold at an average price of $81.44, for a total transaction of $3,737,851.68. Following the completion of the transaction, the insider now directly owns 179,054 shares of the company’s stock, valued at $14,582,157.76. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO Daniel L. Comas sold 96,446 shares of the stock in a transaction that occurred on Wednesday, July 27th. The shares were sold at an average price of $80.88, for a total value of $7,800,552.48. Following the transaction, the chief financial officer now directly owns 215,716 shares of the company’s stock, valued at $17,447,110.08. The disclosure for this sale can be found here. Insiders own 12.60% of the company’s stock.
About Danaher Corp.
Danaher Corporation designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates in five segments: Test & Measurement; Environmental; Life Sciences & Diagnostics; Dental, and Industrial Technologies. Its Test & Measurement segment offers products, software and services.
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corp. (NYSE:DHR).
Receive News & Ratings for Danaher Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Corp. and related companies with MarketBeat.com's FREE daily email newsletter.